Foa R, Migone N, Fierro M T, Basso G, Lusso P, Putti M C, Giubellino M C, Saitta M, Miniero R, Casorati G
Department of Biomedical Sciences and Human Oncology, University of Torino, Italy.
Exp Hematol. 1987 Oct;15(9):942-5.
The reactivity of five anti-B monoclonal antibodies (McAb)-OKB2 (CD24), B4 (CD19), Leu12 (CD19), BA1 (CD24), B1 (CD20)--as well as the presence of cytoplasmic immunoglobulins (CyIg) were assessed in 100 cases of common acute lymphoblastic leukemia (cALL) at presentation (TdT+, J5 [CD10]+, HLA-Dr+). All cases studied revealed one or more B-cell related markers and a hierarchy in their expression was documented: OKB2 was positive in all cases tested (100%), B4 was expressed in 96.4% of cases, Leu12 in 95.8%, BA1 in 94.9%, B1 in 18.3%, and CyIg in 23%. Further evidence of the B-cell origin of cALL was obtained by molecular analyses at the DNA level which demonstrated the presence of an Ig heavy chain gene rearrangement in all 37 cases assessed, while 37.8% showed a light chain gene reorganization. A genomic subclassification of cALL demonstrated that the majority of cases showed an immature molecular configuration with one (8.1%) or both (54.1%) Ig heavy chain alleles rearranged and a germ-line configuration of the light chain genes; 27% revealed a heavy chain gene involvement and one k allele rearranged. Only four cases (10.8%) showed a more mature configuration with both k alleles rearranged or a gamma chain gene involvement. This study confirms that cALL is characterized by the proliferation of immature B-lineage-committed elements and indicates that the leukemic cells are blocked at different levels of B-differentiation which may be recognized with the use of multiple phenotypic or genotypic B-cell-related markers.
评估了5种抗B单克隆抗体(McAb)——OKB2(CD24)、B4(CD19)、Leu12(CD19)、BA1(CD24)、B1(CD20)的反应性,以及100例初诊时的普通急性淋巴细胞白血病(cALL)(末端脱氧核苷酸转移酶阳性、J5[CD10]阳性、HLA-Dr阳性)中细胞质免疫球蛋白(CyIg)的存在情况。所有研究病例均显示一种或多种B细胞相关标志物,并记录了它们表达的层次结构:OKB2在所有检测病例中均呈阳性(100%),B4在96.4%的病例中表达,Leu12在95.8%的病例中表达,BA1在94.9%的病例中表达,B1在18.3%的病例中表达,CyIg在23%的病例中表达。通过DNA水平的分子分析获得了cALL起源于B细胞的进一步证据,该分析表明在评估的所有37例病例中均存在免疫球蛋白重链基因重排,而37.8%的病例显示轻链基因重排。cALL的基因组亚分类表明,大多数病例显示不成熟的分子构型,其中一个(8.1%)或两个(54.1%)免疫球蛋白重链等位基因重排,轻链基因呈种系构型;27%的病例显示重链基因受累且一个κ等位基因重排。只有4例(10.8%)显示更成熟的构型,即两个κ等位基因重排或γ链基因受累。本研究证实cALL的特征是未成熟B系定向细胞的增殖,并表明白血病细胞在B分化的不同水平受阻,这可以通过使用多种表型或基因型B细胞相关标志物来识别。